![Mitchall Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mitchall Clark
Consigliere Generale presso
WHITEHAWK THERAPEUTICS, INC.
Profilo
Mitchall G.
Clark is a Senior VP-Regulatory Affairs & Quality Assurance at Aadi Bioscience, Inc. He previously held positions as Senior Director-Regulatory Affairs at Faulding, Inc. and American Bioscience, Inc., Vice President-Regulatory Affairs at APP Pharmaceuticals, Inc., Senior Vice President-Global Regulatory Affairs at Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs at Celgene Corp., NantWorks LLC, and Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs & Quality at NantPharma LLC, and Chief Regulatory & Quality Assurance Officer at Atara Biotherapeutics, Inc. He also worked as a Principal at Lindum Pharmaceutical Services Corp.
Mr. Clark received an undergraduate degree from The University of Nottingham.
Posizioni attive di Mitchall Clark
| Società | Posizione | Inizio |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Consigliere Generale | 01/08/2018 |
Precedenti posizioni note di Mitchall Clark
| Società | Posizione | Fine |
|---|---|---|
Lindum Pharmaceutical Services Corp. | Corporate Officer/Principal | 01/03/2014 |
NantPharma LLC
 NantPharma LLC Pharmaceuticals: MajorHealth Technology Manufactures injectable pharmaceutical products | Consigliere Generale | 01/06/2013 |
| CELGENE | Consigliere Generale | 01/06/2011 |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Consigliere Generale | 01/11/2007 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Consigliere Generale | 01/04/2006 |
Formazione di Mitchall Clark
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
53
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Faulding, Inc.
 Faulding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells generic drugs | Health Technology |
American Bioscience, Inc.
 American Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Health Technology |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and markets injectable pharmaceutical products | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Health Technology |
NantWorks LLC
 NantWorks LLC Packaged SoftwareTechnology Services Develops and delivers technologies that accelerate to scientific discovery, enhance ground-breaking research and improve healthcare treatment | Technology Services |
NantPharma LLC
NantPharma LLC Pharmaceuticals: MajorHealth Technology Manufactures injectable pharmaceutical products | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Lindum Pharmaceutical Services Corp. | |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
